Research

Harnessing EHR networks to demonstrate value

Payers, providers, and patients are demanding more than the FDA standards of safety and efficacy to justify the value of drugs and devices. They want to know the value of treatments for specific subsets of patients in order to support formulary and purchasing decisions, clinical guideline development, and decision support at the point of care. EHR-based real-world evidence (RWE) is widely purported as a promising tool for delivering on those demands.

By Madhavi Kasinadhuni